118 ?ltdr:qu6n1:f,nurunnuflran{ndrin l:.tr,rorurant:ilnrndrild g sfud a ril.u.-i.u. zozsrdn6ru':ururnfifi fooa alergic colitis firJ:;i6[rVjrslunraunfr, blood eosinophil ql, IgE q{noc t'{u I gE antibodies tfi q sn'irn {ufi rfl u ulcerativecolitis uio Crohn,s disease t?u1vflsfiu1uo .' ' a') ,rlutdnolr{6i'rn'jr z ilfirflu hemorrhagicolitis ar:Crrfl sfi lamrs-ur{udrYuoril1irfi on{'oo11r1:r1rd1guufirornr:ornratilrjrvfrn rnuuflru6 r.il.il n qun nnnn u h wa t a'r am v il n m it oru n ryiEditorials : Traveller's Diarrhoea don't DisregardFurazolidoneMed Prog 1985; l2t7L-72.Enterotoxigenic Escherichia coli, Shigella,Salmonella ttfl r Campylobacter rfl ue r rra qd r fr'rplait travellers diarrhoea g'l Co-trimoxazole(trimethoprim + sulphamethoxazolelf,fnurld'Hnd snriur4o Campylobacter luunoovtona.:fiud'o:ra'lufosnY 53: 1on orlrJtd"ir furazolidone nutf lfl u0'lfn u1lriu'tria[:nooolT;T?.nl[t?nlufllrfisrInguor'{ryuilnlilutttfro Campylobacter unt ShigellaDuPont HL, et al. Furazolidone versus ampicillinin the treatment of travellers diarrhea.Antimicrob Agents Chemother 1984; 26:160.rjrvfin lnrrflruA il.u.th a ry u n nt nfi u Ir tn a 1 a't nrn v il n dt o\ n $Effect of Intraverrous Immurre Globulin m Nehr'ral Killer C"cll Activity : Pmible Associrtiqr withEngelhsrd D, Waner tL, Kapoor N, fuJ Pediatr 1986; 108:7I-81.RA.Autoimmune Neutlopenie 8nd ldiopabic Thtmbocytopenianr:fnull:mnnuaufiuo6fi lrounurirTnnlfiu1ur6ooe1r (hlpogammaglobulinemia) lrnrnf,nrfi ooelufiolilvr:ruer rvrqili a autoimmune neutropeniadu turlclluldld6l4ulnsgfiudonlrnnoordoodr nnlnnr:aanqnffi*folritnlu it1o.nuir6ruXnrlnnryfiufiuhlilcnnr'riliouJdt uuiln.rf4druurllf urazolidone 1f, dr r{o\dnir onr.:loYfi nr: 6n ur uuu double-blind : til'i1'0tt1furazolidone tt03 ampicillin ornfindnsreufgorruinrFc recepton lol mononuclear phagocytes 3 t$inurun!fi'illi8 ells nonr 1 t'ls.t1u {rronunu'ir6lXuIn ngfiurtrtf natural killer activity ao.rillv{du6irutu sa:rs loglf,furazolidone too iln. ilia non$uilaonnnnon :ru.rruildilrnrrfnur{r}ruampicillin soo rR. r1n o dr1u.r lf,nnrlunr:fnur a r106rilrsrflul:nunrrirlnoqfiulurdondr o1qrvirfiurflunnl 5 lu t^ru'irfoan; s5 xo,rndxfilf, s-osfl uo;rllurflultnrnfinrfiooduBnhivnrufurazolidone ldHndnrslu ca drlll n*tfi ampicillinfl1tilq 6n r :rgrilul:fl autoimmune neutropeniateiHnrflsrfoun: gz rdonnrlirillil 72 ritll.rdenrnruosrflufouns zcr cgrfi a uJtsurfi suurfi r z tfiocioriodrfl unrruqfi nu'ir furazolidone tf,::uc trn{unr:fnurrlosn'irampicillin srufihitaHnlunrlf,ulfin z tfioo{lu{rJru e ?1sut r{ryt1{ilnaorfionduurn 3oo iln./nn./n*.r uwilrnrrn: ? e rru d'r ur u r Sn t 6 o o'tlll ri o ubiu r u nc u fr llfu rso-oo urfi HorJ:rng'ir natural killer actvity ono.tz 1u s fls {rJ'lubn autoimmune neutropenia dfi:rdrufouoy 21 : 26 lu:rofi{rhufutJ:;nruuonnaso6i1ild'lsfrlonratd':fu$rrrnro t nlu / an. HnrJ:rng'ir{1ututfint6oorfio flushing type reaction n'l.,fiu{t Srln:flndoufnurguldtse/ou.ll.lu{rhufild'tu furazolidone q.rn'jr ampicillin lu nfi.tfnr*rrlu16' o,aoo/nu.u. natural killer activitydaufnururnn'ir r,ooo LU nonltnda zoLllufrrnrnfnur eiauhnnfiurflulni6n ld{unr:fn$rdru6lryulnnqfiudonirnnanrfiondluurn soo u./flR. {ilrulilnaunuorcionr:fnur d'ru{d'rubn
Vol.3 No.2 Apr.- jun. 1986 J Prapokklao Hosp Clln Med Educat Center I 19lrdoEio steroid uffv cyclophosphamide o:ru{rlru s tu o:radsiorn 6o 16ooirrfi otilvn r uc r ru qfr utd'fuomulo 1 nfil /1:o6n6$nr*r6'rsteroid \d iha daa nt u a af TniJ 6 n 6 h w a n t aut v iln n {t 0"u n G{rhuRR. 61u?14rR fi o rfi aociau 1 rd ruduorn 6,000/ ou.r,rl. fiHnrdolqrflu$!! FSGS fi a:rufidosiour"y"lophosphamidelufiqorfio renal insufficiency 6nriountl'i-nuruflu es,ooo/nu.ilil. 1uiufi r s rad'lornlfr'grufirnoar6n luiufi zo 16-tfrsr6nntmuro soo 2:1ut4lurilur?n 12-16 fl 6.:fi r :rulilldfusr cvciln./nn.drururn6erdaond'ururci:;eiurJn6 \d6o Iophosphamideqrrufrr-lu 10 rdaudlu?urnfiorfioof,.ror.lrjnfi naturalaluh ur:hrif'trl yt.u.killer activity r:rnn'lr t,ooo LU ufi.:orn1frnll:-n:*r aha n un nmn u L iutt.tul a* v iln n #t o\nli-$s ' 2a ) - ) u!, )tol4lRlUARlilO?UYl 20 [Oftl 15.9 LU S{rljltolilRqt",e; u A,Posterior Fracture Dislocation of{udrtathe Hipr$'o.rvro na nfi 6 n o r6ous'ia rur fi f,larilu:; 6'uwithFractures of the Femoral HeadrJn6 uanornfru{?lu.nuu'.JldyiT Rt?nona.3y{ui1Epstein HC, Wiss DA, Cozen L.uonlqfl rosqlo:sfi fizunrirlfr' natural hller activityClin Orthop 1985; 201:9-17.oor o { uoi*aun'jr6 ruXuInu 6udo rfru ooo rfi oo0i'rcuu? urfsrriiur il.u. lorrt:hl4rt :ufilei';uq rmnaqr7aerln n,nfi auil nn ufi nynrr tr Ir r'ria'ril't am v iln n {t olunryi 6'ar'[oi:'unr::-nr*radr.:nrairunrfnullouiforifnt'tfiu r:losnr:6{n:rqnlri'rdrfi ra nrun*.rriudo rfl ufar{rlLate Resistanc€ to Corticosteroids in NephroticSyndromelouuornyrionrlnnro6ou type V o1il Thompsonand Epstein classification ty{:1so:litlfrrdoriioSrivastava RN, Agarwal RK, Moudgil A, Bhuyan UN. ui rr rudo n y}^r n\oi'iu dum:', r, u"' nfr t* uny oi n v1 r1finoJ Pediatr 1986; 108:66-70tr eA o tr16'6nur{rhu nephrotic syndrome 61fi{rlrulrariilnc so-50 rrsrflur?nl 1s fl nu'irfi 14lufind'un: yendulrli'n'ld nr: i'on: yon1fr r{rfi nrutu za :*rlu.:o :\6'H nd n'jr R r: a-o nr y q Rtfrfrr fi nra ra fi.r d { nril riruf rfi t o.:nr q n rfi l n: runu rir u# r nrsu firn.li 6 {nr v q nriJul:n6nunv6ooio steroid 1u.nilfl101'd'o{il?CI bi'uir fi drui 6 atfn f fi u il rai o nr:eir Ci'on: :q nlfiXtooR 2 T'rs rn:r;aroruotsr'tri61rooslfi'nrrifiods r :r8 r{rfi fir urnliln r rurr ad nR: vo nbirfrrf4uiasfin u ru:tltttn; [ilrl1ooqlo 1 t1U rrafiofirjra rz:ru rflums Blln fio:Jnfi ilnnit{fiufdronXrnrvonfiu:nfirin (arnilsd$ovu€l 4:1u orufir3rurflu nephrotic syndrome head f r a gment) fi ft ria ri ldlun r: ri r ri r eYorYo a: l^r nA - qgvi q -6o r -a fl srounuo.lsionr:fnuroim steroid u'rl{ 0.8- rfi a 6'o n'i v o nlri'rrirfi lu: rt lrufl r'r I'i r nrr 11 rilr il'o t'cra, i a'.tt v o )& |13.s fl (ro6l +.s iJ) r{oR'r:o:?orfiotqn^{u'jrri|un: r q nlri'rdr fi 6 r usi u: n o y ld'ru nd rio u n.j rfo s nr so[tuu minimal change a:ru Mesangial proliferativerusifi 6n'jrnr:f,nurd'rui6or$n rifiuilIosnr:6.rn fiu1figlomerulonephritis (MesPGN) z:to $nu ruirfi ufi u.lorir.:r6ar ui onr: rirdrCl'o nruu fi{ (16'H o6Focal segmental glomerulosclerosis (FSGS) t :tu fou oy ae) un;trJa r il1r nfl :,il6.rH nnr:tf,er::lnr rni.r'I A lle Xfl ?110 R 1 :',lu to sD2 ouuotqr ufi o rfi onr:dasia steroid ro.:u'rn::qnfrutrfi rin'ld r,r,r:r:fi nrt6onlui{nnr:ufilflu FSGS 'l6'r4rnr:snrorfiolqo*ofi 2 d"ru?ua :rs,{i{n*.iilrntiJurluu minimal changes 14u'jlln :*rlurir m : u; tu {rJT afi $fi oar1r^rn rndoulu type vdnr: fi: :u s rr nr n r: 6o Err ruH nnr:fn :ldururf, s.rnorflu FSGS frnaruo 1o''t:Jdeiuuirflu cyclophosphamider v{r 1 v ry'd ? s ilr n n d lf a s ns s o o s rfi o nr r :rian rL^r n11 :ru dilru e'tluooufluo.:sionr:fnur zlu rf,arulunrsfifi.r3o,s rluf,rlu[ijut?n1-z fl 6n o :rsfiornlrndltiJuqtrd rduunorru fl.u.
- Page 1 and 2:
TheGlinieal.,,,:J. .,,-:{ , -1.;,'
- Page 3 and 4:
aRutnufmsof.fl..uEil.in.. .-d rrr'
- Page 5 and 6:
J?r: d r: fl.u unr:c'n-n ur r rilr
- Page 7 and 8:
_d?1: dt: fl uun15fin u] Ity{nufl t
- Page 9 and 10:
d 4 d qt11: dt: fl uunr: fl n u] ui
- Page 11 and 12:
Thanxendi s An x io s ele c tivUrel
- Page 13 and 14:
Vol.3 No.2 Apr.- Jun. 1986 J Prapok
- Page 15 and 16:
Vol.3 No.2 Apr.- Jun.1986 J Prapokk
- Page 17 and 18:
Vof.3 No.2 Apr.- Jun. 1986I Prapokk
- Page 19 and 20:
Vol. 3 No.2 Apr.- Jun. 1986I Prapok
- Page 21 and 22: Vof.3 No.2 Apr.- lun.1986J Prapokkl
- Page 23 and 24: Vof.3 No.2 Apr.-.lun. 1986 J Prapok
- Page 25 and 26: Vol.3 No.2 Apr,- Jun. 1985 J Prapok
- Page 27 and 28: Vol.3 No.2 Apr.- |un.1986 I Prapokk
- Page 29 and 30: Vol.3 No.2 Apr.- Jun. .l986 I Prapo
- Page 31 and 32: Vol.3 No.2 Apr.- Jun. 1986 J Prapok
- Page 34 and 35: URFAMrcIN'TO GONORRHEA !fi,lauaflNr
- Page 36 and 37: 86'11:d1:fi udnl:inuruytnufl ren{nd
- Page 38 and 39: 88 2'l : d 1 : fl u d n r : d n ur
- Page 40 and 41: 90 ?r:drtqudnr:dnururnufi ran{n6rin
- Page 42 and 43: 92 ?'l:.r'l:fl udnl:dnurunuuaranSnd
- Page 44 and 45: 94 r 1 t d 1: qu dnr : i n ur unr u
- Page 46 and 47: 96 2r:d1:fludn1:frnuruvtvtuflrasrSn
- Page 48 and 49: 98 ?'l:rtr:rfudnr:dnurttrnuaran{ndr
- Page 50 and 51: 1 O0 ?r:d1: qil6n1: dnurttnnuarasri
- Page 52: LO2 rrttll:{udn'l:dnurttnnofircrnJn
- Page 55 and 56: Vol.3 No. 2 Apr.- Jun, 1986 J Prapo
- Page 57 and 58: Vol.3 No.2 Apr.- jun. 1986.f Prapok
- Page 60 and 61: g.2 Cinopol* 9.3 NoproxenAr EntryAt
- Page 62 and 63: 108 ?1:rr1t{I6n1:dnurutnonran{nirin
- Page 64 and 65: I 1O lrrttl:(udnr:inurunnudrcn{ndrl
- Page 66 and 67: Ll2?1:dr:qu6nl:f,nurttrnnuaranSndin
- Page 68 and 69: I 14 11:.t1:fiudnr:dnurrtntuarcnini
- Page 70 and 71: I 16 ?1:d1:fludnt:dnuruunuflranJndr
- Page 74 and 75: l2O 2'rtd1t{udn1:inuunn0fi rcn{ndrl
- Page 76 and 77: I22 ?r:tY1:qudn1:f,nurunnoarao{n6ri
- Page 78 and 79: 124 ?r:tlrtfludnr:f,nurrtvtnuarasrf
- Page 80 and 81: 126 l:d1:qudnr:inurunnonren{nirin l
- Page 82 and 83: I-eukopenia due to radiation and/or
- Page 84 and 85: 128 21:dr:qudnr:inurunnuarcn{ndrio
- Page 86 and 87: 130 ?'l:dr:{u6n1:inururnudrcnJndrin
- Page 88 and 89: 132 ?1:rtrrfiudnl:dnururnu;rcn{ndri
- Page 90 and 91: 134 2r:tir:(udnt:inurttvtmuarasrini
- Page 92 and 93: mbtlaihil,n/n"nnrsO'lfl...u=rinFaCf
- Page 94 and 95: lFi.o.n. URSICHo'tudtuo t-il4 nlrir
- Page 96 and 97: cTn er a Fitiun ul R't s o't Revlri
- Page 99 and 100: sieunarurj:'rrsrurduiuh rrcrunod tr
- Page 101: TOPICALTHERAPY FORGENITAL HERPESaEf
- Page 104 and 105: Turafhi[rntrin'rst-lo-ln:VmSulnrdld
- Page 106 and 107: PNOTHIADEHConvenientonce-aday dosag
- Page 108: &a"to$riuvprnsvrfrJ. ruei uaul6Cotu
- Page 111 and 112: KENACORT-AIftTACETOilIDERapid contr
- Page 114 and 115: acts faster and stronger3oo.t 6. To
- Page 116 and 117: alcaonuunu.tn'ls-tr-Eur'n Bank Trad
- Page 118 and 119: *ClafOfarfttone or the wortd's most
- Page 121 and 122: E,unu'1R15 01Rhu5rin@ohn-or